REVAL Research Institute, Hasselt University, Diepenbeek, Belgium.
REVAL Research Institute, Hasselt University, Diepenbeek, Belgium; Movement Control & Neuroplasticity Research Group, Department of Movement Sciences, Group Biomedical Sciences, KU Leuven, Heverlee, Belgium.
Clin Neurophysiol. 2021 Aug;132(8):1897-1918. doi: 10.1016/j.clinph.2021.05.015. Epub 2021 Jun 11.
To systematically review how patient characteristics and/or transcranial direct current stimulation (tDCS) parameters influence tDCS effectiveness in respect to upper limb function post-stroke.
Three electronic databases were searched for sham-controlled randomised trials using the Fugl-Meyer Assessment for upper extremity as outcome measure. A meta-analysis and nine subgroup-analyses were performed to identify which tDCS parameters yielded the greatest impact on upper limb function recovery in stroke patients.
Eighteen high-quality studies (507 patients) were included. tDCS applied in a chronic stage yields greater results than tDCS applied in a (sub)acute stage. Additionally, patients with low baseline upper limb impairments seem to benefit more from tDCS than those with high baseline impairments. Regarding tDCS configuration, all stimulation types led to a significant improvement, but only tDCS applied during therapy, and not before therapy, yielded significant results. A positive dose-response relationship was identified for current/charge density and stimulation duration, but not for number of sessions.
Our results demonstrate that tDCS improves upper limb function post-stroke. However, its effectiveness depends on numerous factors. Especially chronic stroke patients improved, which is promising as they are typically least amenable to recovery.
The current work highlights the importance of several patient-related and protocol-related factors regarding tDCS effectiveness.
系统回顾患者特征和/或经颅直流电刺激(tDCS)参数如何影响脑卒中后上肢功能的 tDCS 疗效。
在三个电子数据库中搜索了使用 Fugl-Meyer 上肢评估作为结局测量的假刺激对照随机试验。进行了一项荟萃分析和九项亚组分析,以确定哪些 tDCS 参数对脑卒中患者上肢功能恢复产生最大影响。
纳入了 18 项高质量研究(507 名患者)。慢性期应用 tDCS 的效果优于急性期(亚急性期)应用 tDCS。此外,基线上肢损伤程度较低的患者似乎比基线上肢损伤程度较高的患者从 tDCS 中获益更多。关于 tDCS 配置,所有刺激类型都导致了显著的改善,但只有在治疗期间应用 tDCS,而不是在治疗前应用 tDCS,才会产生显著的效果。电流/电荷密度和刺激持续时间与剂量反应呈正相关,但与治疗次数无关。
我们的结果表明 tDCS 可改善脑卒中后上肢功能。然而,其疗效取决于许多因素。特别是慢性脑卒中患者得到了改善,这很有希望,因为他们通常最不容易恢复。
目前的工作强调了与 tDCS 疗效相关的几个患者相关和方案相关因素的重要性。